Tech Company Financing Transactions

ElevateBio Funding Round

EcoR1 Capital Management, Edbi and F2 Ventures participated in a $170 million Series B venture round for ElevateBio. This VC investment round was announced on 3/31/2020.

Transaction Overview

Company Name
Announced On
3/31/2020
Transaction Type
Venture Equity
Amount
$170,000,000
Round
Series B
Proceeds Purpose
The Series B proceeds will enable: ElevateBio BaseCamp to be fully operational with cGMP manufacturing.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
139 Main St. 500
Cambridge, MA 02142
USA
Phone
Undisclosed
Email Address
Overview
ElevateBio is creating and operating a portfolio of cell and gene therapy companies through partnerships with the world's most innovative scientists and inventors. Together, we leverage our internal bench-to-bedside expertise and to accelerate the development and delivery of therapies -- supported by our broad access to capital.
Profile
ElevateBio LinkedIn Company Profile
Social Media
ElevateBio Company Twitter Account
Company News
ElevateBio News
Facebook
ElevateBio on Facebook
YouTube
ElevateBio on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
David Hallal
  David Hallal LinkedIn Profile  David Hallal Twitter Account  David Hallal News  David Hallal on Facebook
Chief Financial Officer
Vikas Sinha
  Vikas Sinha LinkedIn Profile  Vikas Sinha Twitter Account  Vikas Sinha News  Vikas Sinha on Facebook
Chief Scientific Officer
Mitchell Finer
  Mitchell Finer LinkedIn Profile  Mitchell Finer Twitter Account  Mitchell Finer News  Mitchell Finer on Facebook
VP - Bus. Development
David Backer
  David Backer LinkedIn Profile  David Backer Twitter Account  David Backer News  David Backer on Facebook
VP - Bus. Development
Stacey Hero
  Stacey Hero LinkedIn Profile  Stacey Hero Twitter Account  Stacey Hero News  Stacey Hero on Facebook
VP - Bus. Development
Agustin Melian
  Agustin Melian LinkedIn Profile  Agustin Melian Twitter Account  Agustin Melian News  Agustin Melian on Facebook
VP - Bus. Development
Jeroen van Beek
  Jeroen van Beek LinkedIn Profile  Jeroen van Beek Twitter Account  Jeroen van Beek News  Jeroen van Beek on Facebook
VP - Engineering
Mario Miele
  Mario Miele LinkedIn Profile  Mario Miele Twitter Account  Mario Miele News  Mario Miele on Facebook
VP - Finance
Bhakti Bhargava
  Bhakti Bhargava LinkedIn Profile  Bhakti Bhargava Twitter Account  Bhakti Bhargava News  Bhakti Bhargava on Facebook
VP - General Counsel
Edward Miller
  Edward Miller LinkedIn Profile  Edward Miller Twitter Account  Edward Miller News  Edward Miller on Facebook
VP - Human Resources
Missy Kotchey
  Missy Kotchey LinkedIn Profile  Missy Kotchey Twitter Account  Missy Kotchey News  Missy Kotchey on Facebook
VP - Operations
Michael Paglia
  Michael Paglia LinkedIn Profile  Michael Paglia Twitter Account  Michael Paglia News  Michael Paglia on Facebook
VP - Regulatory Affairs
Douglas Chambers
  Douglas Chambers LinkedIn Profile  Douglas Chambers Twitter Account  Douglas Chambers News  Douglas Chambers on Facebook
VP - Regulatory Affairs
Josh Sorafine
  Josh Sorafine LinkedIn Profile  Josh Sorafine Twitter Account  Josh Sorafine News  Josh Sorafine on Facebook


 

 

Browse more venture capital transactions:

Prev: 3/31/2020: Textio venture capital transaction
Next: 4/1/2020: PhenixP2P venture capital transaction

 

Share this article

 


About Database of VC Transactions

We do our best to report on all VC transactions involving tech companies. VC transactions reported here are derived from a variety of public sources. The data is sourced from VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary